Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is a Phase 2a safety and efficacy study of EVO101 for the treatment of adults with atopic dermatitis
Epistemonikos ID: ee30152255281eaa20ff542119ca0fb4d4fb7191
First added on: May 14, 2024